Panel Urges Closer Scrutiny Of New Medical Technology

When the superficial attraction of the latest equipment outpaces our knowledge of its value, the results can be costly The United States government, concerned about increasing health care costs and unsure about the claims made about some recent technologies, is weighing a proposal that would ask federally funded researchers to prove that new machines are indeed better than their precursors before they become widely used. "The fact is, as technologies emerge, they are driven by those who intro

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share


When the superficial attraction of the latest equipment outpaces our knowledge of its value, the results can be costly
The United States government, concerned about increasing health care costs and unsure about the claims made about some recent technologies, is weighing a proposal that would ask federally funded researchers to prove that new machines are indeed better than their precursors before they become widely used.

"The fact is, as technologies emerge, they are driven by those who introduce them - by industry," says Herbert Abrams, professor of radiology at Stanford University and chairman of an Institute of Medicine panel that issued a report late last year on the state of medical technology assessment. The report, "Assessment of Diagnostic Technology in Health Care," from the Council on Health Care Technology, found much to be upset about. Data collection for large-scale clinical studies may be slipshod or may not follow prescribed methodology, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jan Ziegler

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours